New method of FACS analyzing and sorting of intact whole ovarian fragments (COPAS) after long time (24 h) cooling to 5 °C before cryopreservation.
Wanxue WangMahmoud SalamaPlamen TodorovDimirtry SpitkovskyEvgenia IsachenkoRico BongaartsGohar RahimiPeter MallmannGennady SukhikhVolodimir IsachenkoPublished in: Cell and tissue banking (2021)
As recently announced by the American Society for Reproductive Medicine (ASRM), human ovarian tissue cryopreservation is an established option for fertility preservation in prepubertal girls and young women undergoing gonadotoxic treatments for cancer as well as some autoimmune diseases. Proper ovarian tissue assessment before and after cryopreservation is essential to increase success rates. Ovarian fragments from 16 patients were divided into small pieces in form of cortex with medulla, and randomly divided into the following two groups. Pieces of Group 1 (n = 16) were frozen immediately after operation, thawed and just after thawing their quality was analyzed. Group 2 pieces (n = 16) after operation were cooled to 5 °C for 24 h, then frozen after 24 h pre-cooling to 5 °C, thawed and just after thawing their quality was analyzed. The effectiveness of the pre-freezing cooling of tissue was evaluated by the development and viability of follicles (Calcein-AM and Propidium Iodide) using complex object parametric analyzer and sorter machine (COPAS). Positive effect of cooling of cells to low supra-zero temperatures on their future development after re-warming has been observed. New flow cytometry- technique is suitable for the evaluation and sorting of cryopreserved whole human whole intact ovarian fragments. Long time (24 h) cooling of ovarian tissue to 5 °C before cryopreservation has a trend of a cell viability increasing.
Keyphrases
- endothelial cells
- flow cytometry
- end stage renal disease
- randomized controlled trial
- induced apoptosis
- systematic review
- chronic kidney disease
- oxidative stress
- pregnant women
- induced pluripotent stem cells
- machine learning
- quality improvement
- pluripotent stem cells
- pregnancy outcomes
- signaling pathway
- prognostic factors
- cell death
- current status